Research shows the average Briton spends more than £100 each year on non-prescription medicines such as cough syrup and ...
AbbVie today announced positive topline results from two replicate Phase 3 studies evaluating the safety and efficacy of upadacitinib (RINVOQ®;15 mg, once daily  in adult and adolescent patients ...
Professionally designed and constructed, the Momcozy nasal aspirator offers improved versatility and comfort when it comes to ...
Nasacort takes up to a week to achieve full benefits for allergy symptoms, and should be used daily for optimal allergy ...
Clinical remission rates were over 85% for both TREMFYA® maintenance doses at 96 weeks in both the Phase 3 GRAVITI and GALAXI studies TREMFYA® is the only ...
Lack of sleep isn't the only thing to blame for those dark circles under your eyes. Four doctors share why they happen, and ...